NCORP of the Carolinas (Greenville Health System NCORP)

项目概要/摘要 NCORP的哥伦比亚定位于提供一个持续的，强大的影响癌症护理，通过 在社区环境中进行研究。研究人员承诺将当前的研究和临床实践 基于NCTN研究成果的范式。布基纳法索国家合作方案的目标如下： 让社区肿瘤学家和其他医学专家参与NCTN癌症控制、预防和护理 交付研究，以及嵌入治疗和成像研究中的生活质量研究;提供 成人和儿童社区癌症控制、预防、治疗和护理提供试验机会; 吸引、招募和招收来自社区的参与者，包括代表性不足的少数群体，以及 服务不足的人群;确保所有合格的参与者都有机会获得生物样本 收集;通过研究向社区通报进展;确保准确和及时的数据 提交和遵守方案;与各自的研究基地一起参与概念开发 并确定研究社区差异的机会;加强和改善参与 通过将倡导者纳入研究概念和招募策略， 新的研究人员、合作伙伴和研究人员。 GHS（北部）和棕榈卫生系统（中部地区）扩展到SC健康公司和 联合贷款和资源足以支持未来的增长和应计利润， 哥伦比亚癌症倡议。超过300个临床试验是活跃在任何给定的时间在GHS癌症 研究并包括I期、II期、III期治疗试验、预防试验、症状管理 试验和生活质量试验，所有这些都为患者提供了最新的技术， 关怀连续体从预防到姑息治疗的研究产品确保患者 得到最好的照顾。新的研究计划包括最先进的分子遗传图谱， 目标，使病人留在集水区的尖端治疗量身定制， 他们数据管理对于癌症服务的临床和业务管理都很重要。 哥伦比亚的NCORP准备在NCORP使命的各个方面取得成功，并为 通过让患者参与并开展预期范围的临床试验， 和人体实验

PROJECT SUMMARY/ABSTRACT NCORP of the Carolinas is positioned to provide a sustained, powerful influence on cancer care through research in the community setting. The investigators commit to shift current research and clinical practice paradigms based on the outcomes of NCTN research. The goals of NCORP of the Carolinas are as follows: to engage community oncologists and other medical specialists in NCTN cancer control, prevention, and care delivery research, as well as quality-of-life studies embedded within treatment and imaging studies; to offer the adult and pediatric communities cancer control, prevention, treatment and care delivery trial opportunities; to engage, recruit and enroll participants from the community inclusive of minorities, underrepresented, and underserved populations; to ensure all eligible participants are offered the opportunity for biospecimen collections; to inform the community of advances made through research; to assure accurate and timely data submission and protocol compliance; to participate with the respective research bases in concept development and identification of study opportunities for disparities in the community; to enhance and improve involvement of patient advocates by including advocates in research concepts and recruitment strategies; and to mentor new investigators, partners, and research staff. The expansion of GHS (Upstate) and Palmetto Health System (Midlands) into the SC Health Company and the joint facilities and resources more than adequately support future growth and accruals through NCORP of the Carolinas cancer initiatives. More than 300 clinical trials are active at any given time at the GHS Cancer Institute and include Phase I, Phase II, Phase III treatment trials, prevention trials, symptom management trials, and quality of life trials, all of which provide patients with the latest technology throughout their cancer care continuum. Research offerings across the spectrum from prevention to palliative care ensure patients receive the best care possible. New research initiatives include state-of-the-art genetic mapping for molecular targets that enable patients to stay in the catchment area for cutting-edge treatment tailored specifically to them. Data management is important to both the clinical and business management of cancer services. NCORP of the Carolinas is poised to succeed in all aspects of the NCORP mission and contribute meaningfully to the NCORP goals by engaging patients and conducting the anticipated range of clinical trials and human subject studies.